Sepracor president told analysts that Lunesta share nearing 40%
September 1, 2006
4:00 am
Sepracor president William O’Shea told analysts and investors that Lunesta’s share of the sleep-aid market is nearing 40%, thanks to the company’s aggressive direct-to-patient promotional efforts.
Johnson & Johnson’s McNeil Consumer & Specialty Pharmaceuticals launched a $30 million campaign for chewable Tylenol, targeting a younger-than-usual audience: 30- and 40-somethings with kids.
Merck launches Spanish-language version of Your Health NOw
September 1, 2006
4:00 am
Merck is launching a Spanish-language version of its consumer title Your Health Now.
The FDA slapped Eli Lilly with a warning letter over a patient brochure for its oncology treatment Alimta, saying the mailer glossed over the drug’s indications and failed to mention its risks.